questionsmedicales.fr
Phénomènes biologiques
Phénomènes écologiques et environnementaux
Eutrophisation
Eutrophisation : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Eutrophisation : Questions médicales les plus fréquentes",
"headline": "Eutrophisation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Eutrophisation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-04",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Eutrophisation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes écologiques et environnementaux",
"url": "https://questionsmedicales.fr/mesh/D055669",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes écologiques et environnementaux",
"code": {
"@type": "MedicalCode",
"code": "D055669",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G16.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Prolifération d'algues nuisibles",
"alternateName": "Harmful Algal Bloom",
"url": "https://questionsmedicales.fr/mesh/D057097",
"about": {
"@type": "MedicalCondition",
"name": "Prolifération d'algues nuisibles",
"code": {
"@type": "MedicalCode",
"code": "D057097",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G16.500.285.400"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Eutrophisation",
"alternateName": "Eutrophication",
"code": {
"@type": "MedicalCode",
"code": "D005068",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Boqiang Qin",
"url": "https://questionsmedicales.fr/author/Boqiang%20Qin",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Lake Science and Environment, Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences, 73 East Beijing Road, Nanjing 210008, P. R. China. Electronic address: qinbq@niglas.ac.cn."
}
},
{
"@type": "Person",
"name": "Kang Song",
"url": "https://questionsmedicales.fr/author/Kang%20Song",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China. Electronic address: sk@ihb.ac.cn."
}
},
{
"@type": "Person",
"name": "Peter R Leavitt",
"url": "https://questionsmedicales.fr/author/Peter%20R%20Leavitt",
"affiliation": {
"@type": "Organization",
"name": "Limnology Laboratory, University of Regina, Regina, SK S4S 0A2, Canada. Electronic address: Peter.Leavitt@uregina.ca."
}
},
{
"@type": "Person",
"name": "Meiyi Zhang",
"url": "https://questionsmedicales.fr/author/Meiyi%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Environmental Nanotechnology and Health Effects, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, PR China. Electronic address: myzhang@rcees.ac.cn."
}
},
{
"@type": "Person",
"name": "Gang Pan",
"url": "https://questionsmedicales.fr/author/Gang%20Pan",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Environmental Nanotechnology and Health Effects, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, PR China; Centre of Integrated Water-Energy-Food Studies (iWEF), School of Animal, Rural, and Environmental Sciences, Nottingham Trent University, Brackenhurst Campus, NG25 0QF, UK. Electronic address: gpan@rcees.ac.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37746265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2023.1238883"
}
},
{
"@type": "ScholarlyArticle",
"name": "The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36219319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-022-07903-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay.",
"datePublished": "2024-04-16",
"url": "https://questionsmedicales.fr/article/38635397",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xpro.2024.102987"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38988928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.21037/tcr-24-837"
}
},
{
"@type": "ScholarlyArticle",
"name": "A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37314501",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00280-023-04545-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes biologiques",
"item": "https://questionsmedicales.fr/mesh/D001686"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes écologiques et environnementaux",
"item": "https://questionsmedicales.fr/mesh/D055669"
},
{
"@type": "ListItem",
"position": 4,
"name": "Eutrophisation",
"item": "https://questionsmedicales.fr/mesh/D005068"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Eutrophisation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Eutrophisation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Eutrophisation",
"description": "Comment diagnostiquer l'eutrophisation ?\nQuels tests sont utilisés pour l'eutrophisation ?\nQuels indicateurs montrent l'eutrophisation ?\nPeut-on mesurer l'eutrophisation par satellite ?\nQuel rôle jouent les phytoplanctons dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D005068?mesh_terms=ErbB+Receptors&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Eutrophisation",
"description": "Quels sont les symptômes de l'eutrophisation ?\nComment l'eutrophisation affecte-t-elle la faune aquatique ?\nQuels effets sur la qualité de l'eau ?\nY a-t-il des effets sur la santé humaine ?\nComment l'eutrophisation affecte-t-elle les plages ?",
"url": "https://questionsmedicales.fr/mesh/D005068?mesh_terms=ErbB+Receptors&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Eutrophisation",
"description": "Comment prévenir l'eutrophisation ?\nQuel rôle joue l'agriculture dans la prévention ?\nLes zones tampons sont-elles efficaces ?\nComment sensibiliser le public à l'eutrophisation ?\nLes réglementations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D005068?mesh_terms=ErbB+Receptors&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Eutrophisation",
"description": "Quels traitements existent pour l'eutrophisation ?\nComment réduire les nutriments dans l'eau ?\nLes plantes aquatiques aident-elles ?\nQuelles technologies sont utilisées pour traiter l'eutrophisation ?\nLes algues peuvent-elles être utilisées comme traitement ?",
"url": "https://questionsmedicales.fr/mesh/D005068?mesh_terms=ErbB+Receptors&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Eutrophisation",
"description": "Quelles complications peuvent résulter de l'eutrophisation ?\nComment l'eutrophisation affecte-t-elle les écosystèmes ?\nY a-t-il des impacts économiques ?\nLes algues toxiques causent-elles des problèmes ?\nL'eutrophisation peut-elle entraîner des zones mortes ?",
"url": "https://questionsmedicales.fr/mesh/D005068?mesh_terms=ErbB+Receptors&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Eutrophisation",
"description": "Quels sont les principaux facteurs de risque ?\nComment l'urbanisation contribue-t-elle à l'eutrophisation ?\nLes activités industrielles sont-elles un facteur ?\nQuel impact a l'agriculture intensive ?\nLes changements climatiques influencent-ils l'eutrophisation ?",
"url": "https://questionsmedicales.fr/mesh/D005068?mesh_terms=ErbB+Receptors&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'eutrophisation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'analyse des niveaux de nutriments et l'observation de la prolifération algale."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'eutrophisation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de concentration en nitrates et phosphates dans l'eau sont effectués."
}
},
{
"@type": "Question",
"name": "Quels indicateurs montrent l'eutrophisation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La présence d'algues vertes et une diminution de l'oxygène dissous sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer l'eutrophisation par satellite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des images satellites peuvent détecter la couleur de l'eau et la biomasse algale."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les phytoplanctons dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les phytoplanctons sont souvent mesurés pour évaluer la santé des écosystèmes aquatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'eutrophisation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la prolifération d'algues, la décoloration de l'eau et des odeurs désagréables."
}
},
{
"@type": "Question",
"name": "Comment l'eutrophisation affecte-t-elle la faune aquatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une diminution de l'oxygène, affectant la survie des poissons et autres organismes."
}
},
{
"@type": "Question",
"name": "Quels effets sur la qualité de l'eau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eutrophisation dégrade la qualité de l'eau, rendant celle-ci impropre à la consommation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur la santé humaine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines algues produisent des toxines pouvant nuire à la santé humaine."
}
},
{
"@type": "Question",
"name": "Comment l'eutrophisation affecte-t-elle les plages ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des fermetures de plages en raison de la prolifération d'algues nuisibles."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'eutrophisation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la gestion des nutriments, l'éducation et des réglementations strictes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'agriculture dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agriculture durable et la réduction des engrais chimiques sont essentielles pour prévenir l'eutrophisation."
}
},
{
"@type": "Question",
"name": "Les zones tampons sont-elles efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les zones tampons végétalisées peuvent filtrer les nutriments avant qu'ils n'atteignent l'eau."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le public à l'eutrophisation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'éducation et de sensibilisation peuvent informer sur les impacts de l'eutrophisation."
}
},
{
"@type": "Question",
"name": "Les réglementations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations sur les rejets industriels et agricoles peuvent réduire l'eutrophisation."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'eutrophisation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la réduction des nutriments, l'aération et l'utilisation de produits chimiques."
}
},
{
"@type": "Question",
"name": "Comment réduire les nutriments dans l'eau ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut réduire les nutriments par des pratiques agricoles durables et le traitement des eaux usées."
}
},
{
"@type": "Question",
"name": "Les plantes aquatiques aident-elles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines plantes aquatiques peuvent absorber les nutriments et améliorer la qualité de l'eau."
}
},
{
"@type": "Question",
"name": "Quelles technologies sont utilisées pour traiter l'eutrophisation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des technologies comme la filtration biologique et les systèmes de traitement avancés sont utilisées."
}
},
{
"@type": "Question",
"name": "Les algues peuvent-elles être utilisées comme traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines algues peuvent être récoltées pour réduire les niveaux de nutriments dans l'eau."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter de l'eutrophisation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de biodiversité, la dégradation des habitats aquatiques et des problèmes de santé publique."
}
},
{
"@type": "Question",
"name": "Comment l'eutrophisation affecte-t-elle les écosystèmes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des déséquilibres écologiques, affectant la chaîne alimentaire aquatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des impacts économiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'eutrophisation peut nuire à la pêche, au tourisme et à la qualité de l'eau potable."
}
},
{
"@type": "Question",
"name": "Les algues toxiques causent-elles des problèmes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les algues toxiques peuvent provoquer des intoxications chez les animaux et les humains."
}
},
{
"@type": "Question",
"name": "L'eutrophisation peut-elle entraîner des zones mortes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'eutrophisation peut créer des zones mortes où l'oxygène est insuffisant pour soutenir la vie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'utilisation excessive d'engrais, les eaux usées non traitées et l'urbanisation."
}
},
{
"@type": "Question",
"name": "Comment l'urbanisation contribue-t-elle à l'eutrophisation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'urbanisation augmente le ruissellement des nutriments vers les cours d'eau, aggravant l'eutrophisation."
}
},
{
"@type": "Question",
"name": "Les activités industrielles sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les rejets industriels non régulés peuvent introduire des nutriments dans les écosystèmes aquatiques."
}
},
{
"@type": "Question",
"name": "Quel impact a l'agriculture intensive ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agriculture intensive utilise des engrais qui peuvent s'écouler dans les rivières et lacs, causant l'eutrophisation."
}
},
{
"@type": "Question",
"name": "Les changements climatiques influencent-ils l'eutrophisation ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les changements climatiques peuvent exacerber l'eutrophisation en modifiant les régimes de précipitations."
}
}
]
}
]
}
Hepatocellular carcinoma (HCC) patients at advanced stages receive immunotherapy or treatment with tyrosine kinase inhibitors (TKIs) such as Sorafenib (Sora) or Lenvatinib in frontline as well as Rego...
In this study, we addressed the impact of the receptor tyrosine kinase Axl binding to its ligand Gas6 in acquiring refractoriness to TKIs. The initial responses of Axl-positive and Axl-negative cell l...
We show that HCC cells exhibiting a mesenchymal-like phenotype were less sensitive to drug treatment, linking TKI resistance to changes in epithelial plasticity. Gas6/Axl expression and activation wer...
Together, these data suggest that the inhibition of ErbBs is synthetic lethal with Rego in Axl-expressing HCC cells, showing a novel vulnerability of HCC....
Glioblastoma multiforme (GBM) is an aggressive and lethal brain cancer, which is incurable with standard cancer treatments. miRNAs have great potential to be used for gene therapy due to their ability...
Here, miR-429 was overexpressed using lentiviral vectors in U-251 and U-87 GBM cells and it was observed that the expression level of several oncogenes of the ERBB pathway, EGFR, PIK3CA, PIK3CB, KRAS,...
Altogether, miR-429 seems to be an efficient suppressor of the ERBB genetic signaling pathway and a potential therapeutic for GBM....
The ERBBprofiler assay measures compound effects on ERBB family receptors and key downstream signaling pathways that are implicated in cancer or other complex diseases. Here, we present a protocol for...
Hepatocellular carcinoma (HCC) is a highly heterogeneous and aggressive tumor. In recent years, the incidence of HCC has been increasing worldwide. Despite notable advancements in treatment methodolog...
We performed a comprehensive, narrative review of the latest literature to define the current progress of ErbB family receptors in HCC in both the pre-clinical and clinical arenas....
The ErbB family belongs to the tyrosine kinase (TK) receptor family that comprises four members. These members are closely associated with proliferation, cell cycle regulation, and migration during HC...
Through in-depth research and the application of ErbB-targeted therapy, broader avenues will be opened for the treatment of HCC and other tumors, leading to more personalized and precise treatment app...
Aberrant alterations of ERBB receptor tyrosine kinases lead to tumorigenesis. Single agent therapy targeting EGFR or HER2 has shown clinical successes, but drug resistance often develops due to aberra...
Patients with actionable somatic mutations or amplifications in ERBB genes or actionable KRAS mutations were enrolled to receive neratinib and trametinib in this phase I dose escalation trial. The pri...
Twenty patients were enrolled with a median age of 50.5 years and a median of 3 lines of prior therapy. Grade 3 treatment-related toxicities included: diarrhea (25%), vomiting (10%), nausea (5%), fati...
Neratinib and trametinib combination was toxic and had limited clinical efficacy. This may be due to suboptimal drug dosing given drug-drug interactions....
NCT03065387....
ERBB receptor tyrosine kinases are involved in development and diseases like cancer, cardiovascular, neurodevelopmental, and mental disorders. Although existing drugs target ERBB receptors, the next g...
Gallbladder cancer (GBC) is an aggressive type of digestive system cancer with a dismal outcome. Given the lack of effective treatment options, the disease rapidly reoccurs and 5-year survival rate is...
We conduct a multicentre and randomised study on afatinib combined with gemcitabine and oxaliplatin (GEMOX) in patients with ErbB pathway mutated GBC. Clinical and biological evaluation involving ErbB...
The study was approved by the medical-ethical review committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and Renji Hospital Affiliated to Shanghai Jiao Tong Uni...
NCT04183712....
Epidermal growth factor receptor (EGFR), which is referred to as ErbB1/HER1, is the prototype of the EGFR family of receptor tyrosine kinases which also comprises ErbB2 (Neu, HER2), ErbB3 (HER3), and ...
Current therapies targeting the human epidermal growth factor receptor (HER) family, including monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs), are limited by drug resistance and sy...
Transactivation of epidermal growth factor receptors (EGFR) provides intricate control over multiple regulatory cellular processes that merge the diversity of G protein-coupled receptors (GPCRs) with ...